Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Roucongrong is a traditional Chinese medicine (TCM) derived from the dried fleshy stems of the parasitic herbaceous plants *Cistanche deserticola* Y.C. Ma or *Cistanche tubulosa* (Schenk) Wight. Known as the "Ginseng of the desert," it has been used for nearly 2,000 years in Chinese medicine to tonify kidney yang, replenish essence and blood, and moisten the large intestine to relieve constipation. Modern pharmacological research has identified phenylethanoid glycosides, such as echinacoside and acteoside, as its primary bioactive constituents. These compounds are being investigated for their neuroprotective effects in Parkinson's disease—potentially through the modulation of the Wnt/beta-catenin signaling pathway—as well as for their antioxidant, anti-inflammatory, and anti-osteoporotic properties. It is listed in the Chinese Pharmacopoeia and is commonly administered as a decoction or as part of multi-herb formulas like the Roucongrong Pill (RCRP).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on roucongrong.